logo
Questions? +1 (202) 335-3939 Login
Set Up FREE Account Submit Release
Trusted News Since 1995
A service for pharmaceutical industry professionals · Tuesday, August 25, 2026 · 936,832,819 Articles · 3+ Million Readers
Home  •••  Newswires by Industry  •  Countries  •  U.S. States  •  World Media Directory
Pharmaceutical Industry News  •••  Topics  •  Countries  •  U.S. States

Lucentis News Monitoring

  • Published on Aug 24, 2026

    Outlook Therapeutics Announces the FDA Approval of LYTENAVA™ for Wet AMD

    On July 24, 2026, Outlook Therapeutics announced the FDA approval of Lytenava™ (bevacizumab-vikg) for the treatment of neovascular age-related macular degeneration (“nAMD”), commonly known as wet AMD. According to Outlook, Lytenava™ is the first ophthalmic …

    Source: JD Supra - California - Neutral
  • Published on Aug 18, 2026

    EyePoint plummets on pivotal data for main drug

    EyePoint, a Boston-area biotechnology company, lost nearly a billion dollars in market value Monday after its main drug failed to hit the central goal of a key clinical trial. Titled LUGANO, the trial enrolled roughly 400 people with the less common “wet” …

    Source: BioPharma Dive - Pending
  • Published on Jul 27, 2026

    Outlook finally claims FDA approval for AMD drug

    After three knockbacks by the FDA, Outlook Therapeutics has finally pushed its therapy for wet age-related macular degeneration (AMD) over the finish line in the US. The novel formulation of VEGF inhibitor bevacizumab, approved by the FDA as Lytenava, is …

    Source: pharmaphorum - Neutral
  • Published on Jul 28, 2026

    Outlook Therapeutics’ Recently Approved Therapy Could Become Preferred Anti-VEGF Treatment Option In $8.5B US Retina ...

    BTIG upgraded the stock to ‘Buy’ from ‘Neutral’ after Outlook Therapeutics received regulatory approval for its wet AMD therapy. On Friday, the U.S. Food and Drug Administration approved Lytenava, clearing the therapy ahead of its July 29 decision deadline …

    Source: Asianet Newsable - Center-right
  • Published on Jul 28, 2026

    Outlook: 'Hold' - Caution On LYTENAVA FDA Approval And Cash Needs

    Summary Outlook Therapeutics (OTLK) receives both FDA and European approval for LYTENAVA, targeting wet AMD, but faces significant commercialization challenges. I downgrade OTLK to 'Hold' due to acute cash constraints and the urgent need for …

    Source: Seeking Alpha - Indeterminate
  • Published on Aug 10, 2026

    Byooviz Relaunched

    Byooviz Relaunched Harrow announced the commercial relaunch of Byooviz (ranibizumab-nuna), an FDA-approved biosimilar referencing Lucentis (ranibizumab) and developed by Samsung Bioepis. Byooviz was approved by the FDA in 2021 and was initially …

    Source: Review of Ophthalmology - Neutral
  • Published on Jul 28, 2026

    Age-related macular degeneration

    Injections may be required indefinitely to maintain vision Anti-VEGF drugs These drugs consist of an antibody directed at VEGF. They are injected into the eye where they spread to the retina and block VEGF-induced blood vessel growth. Anti-VEGF drugs have …

    Source: New Zealand Doctor - Neutral
  • «
  • 1
  • »

06 days 18:58:02

Featured Releases

Got News to Share? · Submit · See All
Got news to share? Submit it now.
Load more pharmaceuticals news or search news using your own keywords. There are 936,832,819 articles in our news database.

Online News Monitoring Made Simple

Established in 1995, EIN Newsdesk helps millions of users track breaking news across thousands of trusted websites. Users may set up custom email newsletters and RSS feeds or search among thousands of preset news sections. As a member, you may also submit your own news using the EIN Presswire distribution service. Membership is free and we do not sell or lease any information about you. Press release distribution, dedicated APIs, and custom services generate the revenue that allow us to offer you free basic access.

News by Country & by Industry

Worldwide News Coverage

Track news across more than 5,000 sources by country or industry or search our real-time news index.

Pharmaceutical Industry News by Country >
Pharmaceutical Industry News by U.S. State >
Pharmaceutical Industry News Topics >
Online News Publications >
World News Report >

News Alerts & News Feeds

Custom News Monitoring

News page results can be outputted as RSS or received daily by email. You may also use our NewsPlugin for WordPress.

Create Email Newsletter >
Create RSS Feed >
NewsPlugin for WordPress >

Submit News

PR Distribution Service

Our EIN Presswire's distribution footprint reaches millions. You can upload news which is re-published through EIN Newsdesk, fed into Twitter and Facebook, and onto partner sites, Google News, Bing News, etc.

EIN Presswire >
Events >

World Media Directory

News Media Guide

This is a listing of the world’s TV stations, radio stations, newspapers, and blogs. Last update: 08/11/2026

World Media Directory >

Healthcare & Pharmaceuticals Industry Press Releases

Got News to Share? · Submit · See All
Got news to share? Submit it now.

Healthcare & Pharmaceuticals Events

See All

No event was found.

Become a Member - Join Today!
Join thousands of professionals. Stay current. Stay competitive.
  • Track news from thousands of sources
  • Submit news sources for inclusion in our news tracking algorithm
  • Build your own customized email newsletters
  • Use of our RSS Feeds
  • Includes a complimentary EIN Presswire account plus 1-free release
  • Uncluttered & advertising free news pages

Pharmaceutical Industry Today by EIN Newsdesk & EIN Presswire (a press release distribution service)

Follow EIN Presswire on Facebook, LinkedIn and Substack

Newsmatics Inc., 1025 Connecticut Avenue NW, Suite 1000, Washington, DC 20036 · Contact · About

© 1995-2026 Newsmatics Inc. · All Rights Reserved · General Terms & Conditions · Privacy Policy · Cookie Settings

By continuing to use this site, you agree to our Terms & Conditions, last updated on September 30, 2025.